Nosebleeds
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Nasal mucosa oozing; bleeding and mucosal erosion at the front of the nasal cavity, most of which occur in the Lis area; oozing and bleeding are more obvious, and the oozing surface is large but the bleeding site is clear or generally clear; 2. Age 19-65 years old, gender is not limited; 3. No accidental trauma to the nose; 4. Approved by the Medical Ethics Committee, the patients signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe arterial fluctuating bleeding, allergic constitution, and coagulation dysfunction are temporarily not suitable for this study; 2. Poor compliance; 3. Accompanied by mental illness or intellectual disability, unable to cooperate with treatment; 4. Bleeding caused by trauma, tumor, blood system diseases; 5. Those with other system diseases such as asthma, cardiovascular and cerebrovascular diseases; 6. Those who are participating in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical efficacy;One-time hemostatic cure rate;Stuff retention time in both groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score; | — |
Countries
China
Contacts
Beijing Friendship Hospital Affiliated to Capital Medical University